<!doctype html>
<html lang="en">
  <head>
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <style>
        @import url('https://fonts.googleapis.com/css2?family=Montserrat:ital,wght@0,100;0,300;0,400;1,100;1,300;1,400&family=Open+Sans:wght@300;400&display=swap');
    </style>

    <!-- Bootstrap CSS -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.1/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-+0n0xVW2eSR5OomGNYDnhzAbDsOXxcvSN1TPprVMTNDbiYZCxYbOOl7+AMvyTG2x" crossorigin="anonymous">
    <link href="style.css" rel="stylesheet">
    <title>About</title>
  </head>
  <body>
      <!-- navbar -->
      <nav class="navbar navbar-dark navbar-expand-lg sticky-top">
        <div class="container">
            <a class="navbar-brand" style="padding-top: 0; padding-bottom: 0;">
                <img src="Kurve.png" alt="Kurve Logo" width="146" height="90"> 
            </a>
          <button class="navbar-toggler custom-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarNavDropdown" aria-controls="navbarNavDropdown" aria-expanded="false" aria-label="Toggle navigation">
            <span class="navbar-toggler-icon"></span>
          </button>
          <div class="collapse navbar-collapse" id="navbarNavDropdown">
            <ul class="navbar-nav">
              <li class="nav-item">
                <a class="nav-link active" aria-current="page" href="index.html">Home</a>
              </li>
              <li class="nav-item">
                <a class="nav-link" href="technology.html">Technology</a>
              </li>
              <li class="nav-item">
                <a class="nav-link" href="targetD.html">Target Diseases</a>
              </li>
              <li class="nav-item dropdown">
                <a class="nav-link dropdown-toggle" href="#" id="navbarDropdownMenuLink" role="button" data-bs-toggle="dropdown" aria-expanded="false">
                  Results
                </a>
                <ul class="dropdown-menu" aria-labelledby="navbarDropdownMenuLink">
                  <li><a class="dropdown-item" href="phase_I.html">Early Clincal Results: Suggestion of Relevance in Alzheimer’s Disease</a></li>
                  <li><a class="dropdown-item" href="phase_II.html">Phase II Clincal Results: Proof of Concept as Disease-Modifying in Alzheimer’s</a></li>
                </ul>
              </li>
              <li class="nav-item dropdown">
                <a class="nav-link dropdown-toggle" href="#" id="navbarDropdownMenuLink" role="button" data-bs-toggle="dropdown" aria-expanded="false">
                  About
                </a>
                <ul class="dropdown-menu" aria-labelledby="navbarDropdownMenuLink">
                  <li><a class="dropdown-item" href="about.html">Kurve Therapeutics</a></li>
                  <li><a class="dropdown-item" href="team.html">Team</a></li>
                </ul>
              </li>
            </ul>
          </div>
        </div>
      </nav>
      <!-- /navbar -->
      <!-- body content -->
        <!--    jumbotron-->
  <!-- <div class="jumbotron jumbotron-fluid"title="Photo by Polina Tankilevitch from Pexels">
    <div class="container text-sm-left pt-5">
      <h1 class="display-4"><b>WE ARE</b></h1>
      <p class="display-2"><b>KURVE THERAPEUTICS</b></p>
    </div>
  </div> -->

  <!--    /jumbotron-->
      <section class="facts-block">
        <p class="display-2 mt-5 mb-4"style="text-align: center;"><b>KURVE THERAPEUTICS</b></p>
          <div class="facts-block-inner">
            <!-- <h1 class="display-4" style="text-align: center;"><b>WE ARE</b></h1> -->
            <div class="row mt-4">
                <div class="col-sm-6">
                    <p class="about-paragraph">
                        Kurve Therapeutics, (Lynnwood, Washington and Brooklyn, NY) is a specialty-drug company focused on next-generation treatments for neurodegenerative diseases. 
                        Current therapies for these disorders, especially complex molecules such as monoclonal antibodies, have trouble crossing the blood brain barrier (BBB). 
                        Kurve’s patented technology creates a precisely-controlled turbulent flow that navigates the curved, complex geometry of the nose and accesses the most-penetrable part of the BBB.
                      </p>
                </div>
                <div class="col-sm-6">
                    <p class="about-paragraph">
                        Kurve products have had remarkable, disease-modifying clinical success, improving the lives of Alzheimer’s patients in double-blind, placebo-controlled Phase I and Phase II studies. Phase III initiation is targeted for 2020. 
                        In addition, Kurve patients with Lewy body dementia, Parkinson’s and ALS have also experienced sustained improvements in quality of life. 
                        Kurve’s devices are also involved in research at the US Department of Defense for PTSD and Traumatic Brain Injury. A full list of studies is available on request.
                      </p>
                </div>
            </div>
            <div class="row mt-4">
                <div class="col-sm-6">
                    <p class="about-paragraph">
                        The company was founded by a chronic sinusitis sufferer determined to uncover a drug-delivery solution for symptom relief. Extensive research and prototype development yielded a device that successfully penetrated the entire nasal cavity as well as the paranasal sinuses. 
                        This was an accomplishment heretofore unrealized (considered impossible by some). Nose-to-brain delivery, a long-elusive “holy grail” for treatment of CNS diseases, was the next, obvious target. 
                        The first success in nose-to-brain was demonstrated by Kurve devices administering intranasal insulin for Alzheimer’s disease.
                      </p>
                </div>
                <div class="col-sm-6">
                    <p class="about-paragraph">
                        The drugs used in Kurve devices for neurodegenerative diseases (e.g., Alzheimer’s disease, Lewy body dementia, Parkinson’s disease and ALS) are available in generic form. Kurve Therapeutics therefore possesses all of the relevant intellectual property and in effect owns these breakthrough treatments in neurodegenerative diseases. 
                        Clinical success has already been demonstrated for each of these diseases. Case files for Alzheimer’s and Parkinson’s patients provide profound examples of the potential of this technology platform (please see Appendices 1 & 2).
                      </p>
                </div>
          </div>
      </section>
      <!--/body content-->

    <!-- Optional JavaScript; choose one of the two! -->

    <!-- Option 1: Bootstrap Bundle with Popper -->
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.1/dist/js/bootstrap.bundle.min.js" integrity="sha384-gtEjrD/SeCtmISkJkNUaaKMoLD0//ElJ19smozuHV6z3Iehds+3Ulb9Bn9Plx0x4" crossorigin="anonymous"></script>

    <!-- Option 2: Separate Popper and Bootstrap JS -->
    <!--
    <script src="https://cdn.jsdelivr.net/npm/@popperjs/core@2.9.2/dist/umd/popper.min.js" integrity="sha384-IQsoLXl5PILFhosVNubq5LC7Qb9DXgDA9i+tQ8Zj3iwWAwPtgFTxbJ8NT4GN1R8p" crossorigin="anonymous"></script>
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.1/dist/js/bootstrap.min.js" integrity="sha384-Atwg2Pkwv9vp0ygtn1JAojH0nYbwNJLPhwyoVbhoPwBhjQPR5VtM2+xf0Uwh9KtT" crossorigin="anonymous"></script>
    -->
  </body>
</html>